Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$10.5 million.

  • InflaRx's Free Cash Flow rose 132.72% to -$10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.4 million, marking a year-over-year increase of 978.66%. This contributed to the annual value of -$52.5 million for FY2024, which is 2932.91% down from last year.
  • Per InflaRx's latest filing, its Free Cash Flow stood at -$10.5 million for Q3 2025, which was up 132.72% from -$8.5 million recorded in Q2 2025.
  • In the past 5 years, InflaRx's Free Cash Flow registered a high of -$3.2 million during Q3 2022, and its lowest value of -$16.1 million during Q1 2024.
  • In the last 4 years, InflaRx's Free Cash Flow had a median value of -$11.7 million in 2023 and averaged -$10.9 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 12537.18% in 2023, then surged by 3463.67% in 2025.
  • Quarter analysis of 4 years shows InflaRx's Free Cash Flow stood at -$5.2 million in 2022, then crashed by 125.37% to -$11.7 million in 2023, then fell by 8.82% to -$12.7 million in 2024, then rose by 17.55% to -$10.5 million in 2025.
  • Its last three reported values are -$10.5 million in Q3 2025, -$8.5 million for Q2 2025, and -$14.7 million during Q1 2025.